Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
Pfizer (PFE) Stock Sinks on Weak 2024 View as COVID Sales Fall
09:46am, Thursday, 14'th Dec 2023
Pfizer's (PFE) shares decline almost 7% in response to the muted guidance for 2024. Revenues are expected to be in the range of $58.5 to $61.5 billion, while adjusted EPS is expected in the range of $
Are These 3 Cheap Dividend Stocks With High Yields Too Good to Be True?
08:45am, Thursday, 14'th Dec 2023
Pfizer's valuation has taken a beating this year as its sales slumped 42% last quarter. Falling oil prices and a big acquisition have made this a disappointing year for Enbridge.
Pfizer stock trades at 10-year low; PFE to crash to $20?
05:52am, Thursday, 14'th Dec 2023
After surging to unprecedented peaks in 2021, Pfizer Inc. (NYSE: PFE) faced extreme challenges in 2023, marking a significant downturn for the world's largest drugmaker.
Pfizer's 2024 Outlook Disappointed Wall Street, But Where Will the Stock Be in 5 Years?
05:34am, Thursday, 14'th Dec 2023
Shares of Pfizer recently fell hard after the company announced full-year 2024 guidance. Pfizer also received regulatory approval to complete its proposed $43 billion acquisition of Seagen.
Midday Movers: Vertex Surges on Gene-Editing Deal, Pfizer Falls on Guidance Miss
12:55pm, Wednesday, 13'th Dec 2023
U.S. equities were slightly higher at midday ahead of comments from the Federal Reserve following its last meeting of the year. It's expected the central bank won't raise interest rates any further to
Pfizer shares sink after it resets 2024 COVID expectations
12:40pm, Wednesday, 13'th Dec 2023
Pfizer, Inc. on Wednesday forecast 2024 sales that could be as much as $5 billion below Wall Street expectations, driving shares down 9% to a 10-year low.
3 Sleepy Stocks Ready to Wake up in 2024
12:20pm, Wednesday, 13'th Dec 2023
As 2023 comes to an end, many investors are breathing a little easier about their portfolios. As you start to do your year-end rebalancing you may be looking for stocks to buy for 2024.
Why Pfizer Stock Is Sinking Today
12:14pm, Wednesday, 13'th Dec 2023
Pfizer expects little to no overall revenue growth in 2024. Continued declining sales for the company's COVID-19 products is the main culprit for the weak outlook.
Pfizer Shares Dropped to Their Lowest Level in Over 10 Years—Here's Why
11:40am, Wednesday, 13'th Dec 2023
Pfizer (PFE) shares tumbled over 8% in early trading Wednesday to their lowest level in more than 10 years after warning revenue could decline next year and releasing guidance below forecasts as deman
Pfizer Becomes Oversold
11:32am, Wednesday, 13'th Dec 2023
The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important
Pfizer guides for US$61.5bn sales from Covid-19, Paxlovid, Seagen
10:23am, Wednesday, 13'th Dec 2023
Pfizer Inc (NYSE:PFE) said today that it is expecting $58.5 billion to $61.5 billion of sales in 2024 from Covid-19 vaccines, antiviral medicine Paxlovid and Seagen, with deal for the latter cancer dr
2 Big-Name Stocks Are Falling Wednesday -- Here's Why
09:54am, Wednesday, 13'th Dec 2023
Markets were mixed at the open on Wednesday morning. Pfizer shares dropped after the drug giant revealed 2024 guidance.
Pfizer shares fall as 2024 revenue and profit forecast disappoints
09:40am, Wednesday, 13'th Dec 2023
After raking in billions from Covid products, Pfizer has struggled to navigate a world beyond the pandemic and reassure investors about its growth potential.
Pfizer Stock Sinks To 10-Year Low—Why Investors Have Soured On Covid-Era Giant
09:38am, Wednesday, 13'th Dec 2023
Pfizer stock's struggles continued Wednesday, as shares of the healthcare titan dropped to their lowest level since before the Covid-19 pandemic, the latest dubious milestone for the battered stock th
Why is Pfizer stock being punished this morning?
09:36am, Wednesday, 13'th Dec 2023
Pfizer Inc (NYSE: PFE) opened about 9.0% down on Wednesday after its management issued guidance for the coming year that fell short of Street estimates. Pfizer's earnings and revenue outlook for 2024
